Inhibitors of Protein Translocation Across the ER Membrane

Traffic

Volumn 16, Issue 10, 2015, Pages 1027-1038

  Kalies, Kai Uwe ^a   Römisch, Karin ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Antigen cross presentation; Endoplasmic reticulum; ER associated degradation; Membrane protein integration; Protein secretion; Protein translocation; Sec61 channel

Indexed keywords

CALMODULIN INHIBITOR; CHAPERONE; CYCLODEPSIPEPTIDE; EXOTOXIN; LACTONE DERIVATIVE; LANTHANUM; MEMBRANE PROTEIN; STEROL; ANTINEOPLASTIC AGENT; CARRIER PROTEIN;

ANTIGEN PRESENTATION; ENDOPLASMIC RETICULUM MEMBRANE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN SECRETION; PROTEIN TRANSPORT; REVIEW; ANIMAL; CYTOSOL; DRUG EFFECTS; ENDOPLASMIC RETICULUM; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; CYTOSOL; ENDOPLASMIC RETICULUM; HUMANS; MEMBRANE TRANSPORT PROTEINS; PROTEIN TRANSPORT;

EID: 84941601044     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/tra.12308     Document Type: Review

References (76)

1. Wicker W, Schekman R. Protein translocation across biological membranes. Science 2005;310:1452-1456.
2. Luesch H, Yoshida WY, Moore RE, Paul VJ. New apratoxins of marine cyanobacterial origin from guam and palau. Bioorg Med Chem 2002;10:1973-1978.
3. Junne T, Wong J, Studer C, Aust T, Bauer BW, Beibel M, Bhullar B, Bruccoleri R, Eichenberger J, Estoppey D, Hartmann N, Knapp B, Krastel P, Melin N, Oakeley EJ, et al. Decatransin, a novel natural product inhibiting protein translocation at the Sec61/SecY translocon. J Cell Sci 2015;128:1217-1229.
4. Römisch K. Endoplasmic reticulum-associated degradation. Annu Rev Cell Dev Biol 2005;21:435-456.
5. Park E, Rapoport TA. Mechanisms of Sec61/SecY-mediated protein translocation across membranes. Annu Rev Biophys 2012;41:21-40.
6. Shao S, Hegde RS. A calmodulin-dependent translocation pathway for small secretory proteins. Cell 2011;147:1576-1588.
7. Lakkaraju AK, Thankappan R, Mary C, Garrison JL, Taunton J, Strub K. Efficient secretion of small proteins in mammalian cells relies on Sec62-dependent posttranslational translocation. Mol Biol Cell 2012;23:2712-2722.
8. Austen BM, Hermon-Taylor J, Kaderbhai MA, Ridd DH. Design and synthesis of a consensus signal sequence that inhibits protein translocation into rough microsomal vesicles. Biochem J 1984;224:317-325.
9. Vermeire K, Bell TW, Van Puyenbroeck V, Giraut A, Noppen S, Liekens S, Schols D, Hartmann E, Kalies KU, Marsh M. Signal Peptide-binding drug as a selective inhibitor of co-translational protein translocation. PLoS Biol 2014;12:e1002011.
10. Fewell SW, Day BW, Brodsky JL. Identification of an inhibitor of hsc70-mediated protein translocation and ATP hydrolysis. J Biol Chem 2001;276:910-914.
11. Fewell SW, Smith CM, Lyon MA, Dumitrescu TP, Wipf P, Day BW, Brodsky JL. Small molecule modulators of endogenous and co-chaperone-stimulated Hsp70 ATPase activity. J Biol Chem 2004;279:51131-51140.
12. Patham B, Duffy J, Lane A, Davis RC, Wipf P, Fewell SW, Brodsky JL, Mensa-Wilmot K. Post-translational import of protein into the endoplasmic reticulum of a trypanosome: an in vitro system for discovery of anti-trypanosomal chemical entities. Biochem J 2009;419:507-517.
13. Sugie Y, Inagaki S, Kato Y, Nishida H, Pang CH, Saito T, Sakemi S, Dib-Hajj F, Mueller JP, Sutcliffe J, Kojima Y. CJ-21, 058, a new SecA inhibitor isolated from a fungus. J Antibiot (Tokyo) 2002;55:25-29.
14. Vesonder RF, Tjarks LW, Rohwedder WK, Burmeister HR, Laugal JA. Equisetin, an antibiotic from Fusarium equiseti NRRL 5537, identified as a derivative of N-methyl-2, 4-pyrollidone. J Antibiot 1979;32:759-761.
15. Zimmermann R, Zimmermann M, Wiech H, Schlenstedt G, Müller G, Morel F, Klappa P, Jung C, Cobet WWE. Ribonucleoparticle-independent transport of proteins into mammalian microsomes. J Bioenerg Biomembr 1990;22:711-723.
16. Erdmann F, Schäuble N, Lang S, Jung M, Honigmann A, Ahmad M, Dudek J, Benedix J, Harsman A, Kopp A, Helms V, Cavalie A, Wagner R, Zimmermann R. Interaction of calmodulin with Sec61alpha limits calcium leakage from the endoplasmic reticulum. EMBO J 2011;30:17-31.
17. Erdmann F, Jung M, Eyrisch S, Lang S, Helms V, Wagner R, Zimmermann R. Lanthanum ions inhibit the mammalian Sec61 complex in its channel dynamics and protein transport activity. FEBS Lett 2009;583:2359-2364.
18. Andersen OS, Koeppe RE. Bilayer thickness and membrane protein function: an energetic perspective. Annu Rev Biophys Biomol Struct 2007;36:107-130.
19. Phillips R, Ursell T, Wiggins P, Sens P. Emerging roles for lipids in shaping membrane-protein function. Nature 2009;459:379-385.
20. Bretscher MS, Munro S. Cholesterol and the Golgi apparatus. Science 1993;261:1280-1281.
21. Sharpe HJ, Stevens TJ, Munro S. A comprehensive comparison of transmembrane domains reveals organelle-specific properties. Cell 2010;142:158-169.
22. Bogdanov M, Xie J, Heacock P, Dowhan W. To flip or not to flip: lipid-protein charge interactions are a determinant of final membrane topology. J Cell Biol 2008;182:925-935.
23. Nilsson IM, Ohvo-Rekilä H, Slotte JP, Johnson AE, von Heijne G. Inhibition of protein translocation across the endoplasmic reticulum membrane by sterols. J Biol Chem 2001;276:41748-41754.
24. Nyholm TK. Lipid-protein interplay and lateral organization of biomembranes. Chem Phys Lipids 2015;189:48-55.
25. Lange Y, Steck TL. Four cholesterol-sensing proteins. Curr Opin Struct Biol 1998;8:435-439.
26. Leheny EA, Theg SM. Apparent inhibition of chloroplast protein import by cold temperatures is due to energetic considerations not membrane fluidity. Plant Cell 1994;6:427-437.
27. Römisch K, Collie N, Soto N, Logue J, Lindsay M, Scheper W, Cheng C-HC. Protein translocation across the endoplasmic reticulum membrane in cold-adapted organisms. J Cell Sci 2003;116:2875-2883.
28. Yamamoto H, Fujita H, Kida Y, Sakaguchi M. Pleiotropic effects of membrane cholesterol upon translocation of protein across the endoplasmic reticulum membrane. Biochemistry 2012;51:3596-3605.
29. Brambillasca S, Yabal M, Soffientini P, Stefanovic S, Makarow M, Hegde RS, Borgese N. Transmembrane topogenesis of a tail-anchored protein is modulated by membrane lipid composition. EMBO J 2005;24:2533-2542.
30. Feng B, Yao PM, Li Y, Devlin CM, Zhang D, Harding HP, Sweeney M, Rong JX, Kuriakose G, Fisher EA, Marks AR, Ron D, Tabas I. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol 2003;5:781-791.
31. Li Y, Ge M, Ciani L, Kuriakose G, Westover EJ, Dura M, Covey DF, Freed JH, Maxfield FR, Lytton J, Tabas I. Enrichment of endoplasmic reticulum with cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2b activity in parallel with increased order of membrane lipids. J Biol Chem 2004;279:37030-37039.
32. Brodsky JL. Cleaning up: ER-associated degradation to the rescue. Cell 2012;151:1163-1167.
33. Koopmann JO, Albring J, Hüter E, Bulbuc N, Spee P, Neefjes J, Hämmerling GJ, Momburg F. Export of antigenic peptides from the endoplasmic reticulum intersects with retrograde protein translocation through the Sec61p channel. Immunity 2000;13:117-127.
34. Ackerman AL, Giodini A, Cresswell P. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 2006;25:607-617.
35. Zehner M, Marschall AL, Bos E, Schloetel JG, Kreer C, Fehrenschild D, Limmer A, Ossendorp F, Lang T, Koster AJ, Dübel S, Burgdorf S. The translocon protein Sec61 mediates antigen transport from endosomes in the cytosol for cross-presentation to CD8+ T cells. Immunity 2015;42:850-863.
36. Bogerd DL, Chen Y, Foster CA. Synthesis and evaluation of Aza HUN-7293. Bioorg Med Chem Lett 2000;10:1741-1744.
37. Foster CA, Dreyfuss M, Mandak B, Meingassner JG, Naegeli HU, Nussbaumer A, Oberer L, Scheel G, Swoboda EM. Pharmacological modulation of endothelial cell-associated adhesion molecule expression: implications for future treatment of dermatological diseases. J Dermatol 1994;21:847-854.
38. Winiski AP, Foster CA. ICAM-1 expression in a spontaneously transformed human keratinocyte cell line: characterization by a simple cell-ELISA assay. J Invest Dermatol 1992;99:48-52.
39. Hommel U, Weber HP, Oberer L, Naegeli HU, Oberhauser B, Foster CA. The 3D-structure of a natural inhibitor of cell adhesion molecule expression. FEBS Lett 1996;379:69-73.
40. Chen Y, Bilban M, Foster CA, Boger DL. Solution-phase parallel synthesis of a pharmacophore library of HUN-7293 analogues: a general chemical mutagenesis approach to defining structure-function properties of naturally occurring cyclic (depsi)peptides. J Am Chem Soc 2002;124:5431-5440.
41. Besemer J, Harant H, Wang S, Oberhauser B, Marquardt K, Foster CA, Schreiner EP, de Vries JE, Dascher-Nadel C, Lindley IJ. Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1. Nature 2005;436:290-293.
42. Harant H, Lettner N, Hofer L, Oberhauser B, de Vries JE, Lindley IJ. The translocation inhibitor CAM741 interferes with vascular cell adhesion molecule 1 signal peptide insertion at the translocon. J Biol Chem 2006;281:30492-30502.
43. Harant H, Wolff B, Schreiner EP, Oberhauser B, Hofer L, Lettner N, Maier S, de Vries JE, Lindley IJ. Inhibition of vascular endothelial growth factor cotranslational translocation by the cyclopeptolide CAM741. Mol Pharmacol 2007;71:1657-1665.
44. Garrison JL, Kunkel EJ, Hegde RS, Taunton J. A substrate-specific inhibitor of protein translocation into the endoplasmic reticulum. Nature 2005;436:285-289.
45. Kang SW, Rane NS, Kim SJ, Garrison JL, Taunton J, Hegde RS. Substrate-specific translocational attenuation during ER stress defines a pre-emptive quality control pathway. Cell 2006;127:999-1013.
46. Westendorf C, Schmidt A, Coin I, Furkert J, Ridelis I, Zampatis D, Rutz C, Wiesner B, Rosenthal W, Beyermann M, Schülein R. Inhibition of biosynthesis of human endothelin B receptor by the cyclodepsipeptide cotransin. J Biol Chem 2011;286:35588-35600.
47. Klein W, Westendorf C, Schmidt A, Conill-Cortes M, Rutz C, Blohs M, Beyermann M, Protze J, Krause G, Krause E, Schühlein R. Defining a conformational consensus motif in cotransin-sensitive signal sequences: a proteomic and site-directed mutagenesis study. PLoS One 2015;10:e0120886.
48. Choi I, Kim J, Park JY, Kang SW. Cotransin induces accumulation of a cytotoxic clusterin variant that cotranslationally rerouted to the cytosol. Exp Cell Res 2013;319:1073-1082.
49. Maifeld SV, MacKinnon AL, Garrison JL, Sharma A, Kunkel EJ, Hegde RS, Taunton J. Secretory protein profiling reveals TNF-alpha inactivation by selective and promiscuous Sec61 modulators. Chem Biol 2011;18:1082-1088.
50. MacKinnon AL, Paavilainen VO, Sharma A, Hegde RS, Taunton J. An allosteric Sec61 inhibitor traps nascent transmembrane helices at the lateral gate. Elife 2014;3:e01483.
51. MacKinnon AL, Garrison JL, Hegde RS, Taunton J. Photo-leucine incorporation reveals the target of a cyclodepsipeptide inhibitor of cotranslational translocation. J Am Chem Soc 2007;129:14560-14561.
52. Luesch H, Yoshida WY, Moore RE, Paul VJ, Corbett TH. Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula. J Am Chem Soc 2001;123:5418-5423.
53. Luesch H, Chanda SK, Raya RM, DeJesus PD, Orth AP, Walker JR, Izpisua Belmonte JC, Schultz PG. A functional genomics approach to the mode of action of apratoxin A. Nat Chem Biol 2006;2:158-167.
54. Liu Y, Law BK, Luesch H. Apratoxin A reversibly inhibits the secretory pathway by preventing cotranslational translocation. Mol Pharmacol 2009;76:91-104.
55. Azzi A, Azzone GF. Potassium transport-linked swelling induced by valinomycin in liver mitochondria. Biochem J 1965;96:1C-2C.
56. Ryoo IJ, Park HR, Choo SJ, Hwang JH, Park YM, Bae KH, Shin-Ya K, Yoo ID. Selective cytotoxic activity of valinomycin against HT-29 human colon carcinoma cells via down-regulation of GRP78. Biol Pharm Bull 2006;29:817-820.
57. Kim J, Choi I, Park JY, Kang SW. Specific inhibition of hamster prion protein translocation by the dodecadepsipeptide valinomycin. Exp Cell Res 2013;319:2049-2057.
58. Klein B, Worndl K, Lutz-Meindl U, Kerschbaum HH. Perturbation of intracellular K(+) homeostasis with valinomycin promotes cell death by mitochondrial swelling and autophagic processes. Apoptosis 2011;16:1101-1117.
59. Rose L, Jenkins ATA. The effect of the ionophore valinomycin on biomimetic solid supported lipid DPPTE/EPC membranes. Bioelectrochemistry 2007;70:387-393.
60. Vermeire K, Princen K, Hatse S, De Clercq E, Dey K, Bell TW, Schols D. CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro. AIDS 2004;18:2115-2125.
61. Vermeire K, Zhang Y, Princen K, Hatse S, Samala MF, Dey K, Choi HJ, Ahn Y, Sodoma A, Snoeck R, Andrej G, De Clercq E, Bell TW, Schols D. CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor. Virology 2002;302:342-353.
62. Vermeire K, Bell TW, Choi HJ, Jin Q, Samala MF, Sodoma A, De Clercq E, Schols D. The anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptor. Mol Pharmacol 2003;63:203-210.
63. George KM, Chatterjee D, Gunawardana G, Welty D, Hayman J, Lee R, Small PLC. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 1999;283:854-857.
64. Stinear TP, Mve-Obiang A, Small PL, Frigui W, Prior MJ, Brosch R, Jenkin GA, Johnson PD, Davies JK, Lee RE, Adusumilli S, Garnier T, Haydock SF, Leadlay PF, Cole ST. Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans. Proc Natl Acad Sci USA 2004;101:1345-1349.
65. Simmonds RE, Lali FV, Smallie T, Small PL, Foxwell BM. Mycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism. J Immunol 2009;182:2194-2202.
66. Hall BS, Hill K, McKenna M, Ogbechi J, High S, Willis AE, Simmonds RE. The pathogenic mechanism of the Mycobacterium ulcerance virulence factor, mycolactone, depends on blockade of protein translocation into the ER. PLoS Pathog 2014;10:e1004061.
67. Fiebiger E, Hirsch C, Vyas JM, Gordon E, Ploegh HL, Tortorella D. Dissection of the dislocation pathway for type I membrane proteins with a new small molecule inhibitor, eeyarestatin. Mol Biol Cell 2004;15:1635-1646.
68. Wang Q, Li L, Ye Y. Inhibition of p97-dependent protein degradation by eeyarestatin I. J Biol Chem 2008;283:7445-7454.
69. Cross BCS, McKibbin C, Callan AC, Roboti P, Piancenti M, Rabu C, Wilson CM, Whitehead R, Flitsch SL, Pool MR, High S, Swanton E. Eeyarestatin I inhibits Sec61-mediated protein translocation at the endoplasmic reticulum. J Cell Sci 2009;122:4393-4400.
70. Aletrari M-O, McKibbin C, Williams H, Pawar V, Pietroni P, Lord JM, Flitsch SL, Whitehead R, Swanton E, High S, Spooner RA. Eeyarestatin 1 interferes with both retrograde and anterograde intracellular trafficking pathways. PLoS One 2011;6:e22713.
71. Wang Q, Shinkre BA, Lee J, Weniger MA, Liu Y, Chen W, Wiestner A, Trenkle WC, Ye Y. The ERAD inhibitor Eeyarestatin I is a bifunctional compound with a membrane-binding domainand a p97/VCP inhibitory group. PLoS One 2010;5:e15479.
72. McKibbin C, Mares A, Piacenti M, Williams H, Roboti P, Puumalainen M, Callan AC, Lesiak-Mieczkowska K, Linder S, Harant H, High S, Flitsch SL, Whitehead RC, Swanton E. Inhibition of protein translocation at the endoplasmic reticulum promotes activation of the unfolded protein response. Biochem J 2012;442:639-648.
73. Gillece P, Pilon M, Römisch K. The protein translocation channel mediates glycopeptide export across the endoplasmic reticulum membrane. Proc Natl Acad Sci USA 2000;97:4609-4614.
74. Jackson ME, Simpson JC, Girod A, Pepperkok R, Roberts LM, Lord JM. The KDEL retrieval system is exploited by Pseudomonas exotoxin A, but not by shiga-like toxin-1 during retrograde transport from the Golgi complex to the endoplasmic reticulum. J Cell Sci 1999;112:467-475.
75. Wirth A, Jung M, Bies C, Frien M, Tyedmers J, Zimmermann R, Wagner R. The Sec61 complex is a dynamic precursor activated channel. Mol Cell 2003;12:261-268.
76. Schäuble N, Cavalie A, Zimmermann R, Jung M. Interaction of Pseudomonas aeruginosa exotoxin A with the human Sec61 complex suppresses passive calcium efflux from the endoplasmic reticulum. Channels (Austin) 2014;8:76-83.